MolecularMD - Ownership and Business Overview

Life ScienceCompany

MolecularMD Ownership

Who owns MolecularMD?

MolecularMD is owned by ICON. It was acquired on February 21, 2019.

Was MolecularMD formerly PE-backed?

Yes. MolecularMD was formerly owned by 1 private investor.

MolecularMD Business Overview

Where is MolecularMD headquartered?

MolecularMD is headquartered in Portland, Oregon.

What sector is MolecularMD in?

MolecularMD is a life science company.

When was MolecularMD founded?

MolecularMD was founded in 2005.

Life Science M&A Summary in 2019

Out of 60 sectors in the Mergr database, life science ranked 9 in number of deals in 2019. The largest life science acquisition in 2019 was Celgene - which was acquired by Bristol-Myers Squibb for $74.0B.

Join Mergr to view all 252 acquisitions of life science companies in 2019, including 45 acquisitions by private equity firms, and 207 by strategics.

MolecularMD

MolecularMD Corp.

1341 SW Custer Drive,
Portland, Oregon 97219
United States,
(503) 459-4974
www.molecularmd.com

MolecularMD company specializing in clinical development and commercialization of state-of-the-art assays to measure patient response and resistance to targeted cancer therapies. The company serves pharmaceutical and biotech drug developers. MolecularMD was founded in 2005 and is based in Portland, Oregon.


 Subscribe to unlock this and 209,180
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.